Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T11:04:52.533Z Has data issue: false hasContentIssue false
  • English
  • Français

Moyamoya Syndrome Associated with Mucolipidosis-II

Published online by Cambridge University Press:  20 October 2014

P. de Guzman ,
M. Hamilton ,
A. Khan ,
M. Eesa  and
A. Kirton
P. de Guzman
Affiliation:
Calgary Pediatric Stroke Program, Section of Neurology
M. Hamilton
Affiliation:
Division of Neurosurgery, Department of Clinical Neurosciences
A. Khan
Affiliation:
Department of Medical Genetics and Pediatrics, Alberta Children's Hospital Research Institute
M. Eesa
Affiliation:
Department of Radiology, University of Calgary, Calgary, Alberta, Canada
A. Kirton*
Affiliation:
Calgary Pediatric Stroke Program, Section of Neurology
*
Section of Neurology, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB, Canada T3B 6A8. Email: adam.kirton@albertahealthservices.ca.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Information
Canadian Journal of Neurological Sciences , Volume 41 , Issue 4 , July 2014 , pp. 522 - 524
Copyright
Copyright © The Canadian Journal of Neurological 2014

References

1.Miyatake, S, Miyake, N, Touho, H, et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78(11):803–10.CrossRefGoogle ScholarPubMed
2.Scott, RM, Smith, ER.Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37.CrossRefGoogle ScholarPubMed
3.Tiede, S, Storch, S, Lubke, T, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med. 2005;11(10):1109–12.CrossRefGoogle ScholarPubMed
4.Mori, N, Mugikura, S, Higano, S, et al. The leptomeningeal “ivy sign” on fluid-attenuated inversion recovery MR imaging in Moyamoya disease: a sign of decreased cerebral vascular reserve? AJNR Am J Neuroradiol. 2009;30(5):930–5.CrossRefGoogle ScholarPubMed
5.Roach, ES, Golomb, MR, Adams, R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39(9):2644–91.CrossRefGoogle ScholarPubMed
6.Siles, A, Mitchell, GA, Dahdah, NS.An infant with mucolipidosis-II and an atretic orifice of the left coronary artery. Cardiol Young. 2010;20(1):97–9.CrossRefGoogle Scholar
7.Romao, EA, Lourenco, CM, Junior, WM, et al. What lies beneath: Fabry nephropathy in a female patient with severe cerebrovascular disease. Clin Nephrol. 2013;79(4):330–4.CrossRefGoogle Scholar
8.Aerts, JM, Groener, JE, Kuiper, S, et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci USA. 2008;105(8):2812–7.CrossRefGoogle ScholarPubMed